Abstract
Tuberculosis (TB) remains one of the main causes of death by infection, especially in immunocompromised patients [...].
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Immunocompromised Host
-
Tuberculosis*
-
Virulence Factors*
Grants and funding
The authors of this issue were funded by the project INF-ACT “One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases PE00000007”, PNRR Mission 4, funded by EU “NextGenerationEU”—D.D. MUR Prot.n. 0001554 of 11/10/2022 and BactiVax—Anti-Bacterial Innovative Vaccines, Marie Skłodowska-Curie Actions, GA 860325.